BD Reports Third Quarter Fiscal 2026 Financial Results

{
  "signal_id": "b8c176bd-f064-aa55-40e1-84f368f8a5e6",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-08-06T10:30:00+00:00",
  "company": {
    "name": "BD",
    "domain": "bd.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/bd-reports-third-quarter-fiscal-2026-financial-results-302844166.html",
    "title": "BD Reports Third Quarter Fiscal 2026 Financial Results",
    "excerpt": "FRANKLIN LAKES, N.J. , Aug. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced results for its fiscal 2026 third quarter, which ended June 30, 2026. \"We delivered a strong third quarter, with revenue, adjusted operating margin and adjusted EPS all ahead of our expectations,\" said Tom Polen, chairman, CEO and president of BD. \"Our first full quarter as New BD demonstrates the early benefits of a more focused MedTech company, with strong momentum across our key growth platforms, continued innovation and further progress through BD Excellence. We remain focused on disciplined execution, advancing our key growth platforms, expanding margins and allocating capital strategically to drive sustainable growth and long-term shareholder value.\" Recent Business Highlights Basis of Presentation - Continuing Operations On February 9, 2026, the company completed the spin-off of BD's former Biosciences and Diagnostic Solutions business and the combination of the business with Waters Corporation (\"Waters\"). The historical results of the former Biosciences and Diagnostic Solutions business, which was previously the Life Sciences segment, are reflected as discontinued operations for all periods presented. Financial information presented in this release reflects BD's results on a continuing operations basis. Prior...",
    "summary": "BD (Becton, Dickinson and Company) reported revenues of $4.983 billion for the third quarter of fiscal year 2026, which ended on June 30, 2026.",
    "location": "Franklin Lakes, N.J.",
    "planning": false,
    "confidence": 0.95,
    "published_at": "2026-08-06T10:30:00Z",
    "location_data": [
      {
        "city": "Franklin Lakes",
        "state": "New Jersey",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-06-30",
    "article_sentence": "BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced results for its fiscal 2026 third quarter, which ended June 30, 2026.",
    "amount_normalized": 4983
  }
}

curl https://signals.autobound.ai/v1/signals/b8c176bd-f064-aa55-40e1-84f368f8a5e6 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"bd.com","limit":20}'